Ion channel activity of HIV-1 Vpu is dispensable for counteraction of CD317. (Q39538757)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21601230%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Ion channel activity of HIV-1 Vpu is dispensable for counteraction of CD317 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21601230%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21601230%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Gerhard Thiel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21601230%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Sebastian Bolduan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21601230%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Jörg Votteler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21601230%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Veronika Lodermeyer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21601230%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Herwig Koppensteiner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21601230%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Michael Schindler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21601230%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Ulrich Schubert

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21601230%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

English

0 references

publication date

23 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21601230%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21601230%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

416

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21601230%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21601230%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

75-85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21601230%20AND%20SRC:MED&resulttype=core&format=json

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

1 February 2020

cites work

2 references

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

7 January 2021

A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Identification of a protein encoded by the vpu gene of HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Analysis of human immunodeficiency virus type 1 Gag ubiquitination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Molecular dynamics investigation of membrane-bound bundles of the channel-forming transmembrane domain of viral protein U from the human immunodeficiency virus HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Biophysical characterization of Vpu from HIV-1 suggests a channel-pore dualism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Simulation of the HIV-1 Vpu transmembrane domain as a pentameric bundle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Identification of a region within the cytoplasmic domain of the subtype B Vpu protein of human immunodeficiency virus type 1 (HIV-1) that is responsible for retention in the golgi complex and its absence in the Vpu protein from a subtype C HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Tetherin inhibits HIV-1 release by directly tethering virions to cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Inhibition of Lassa and Marburg virus production by tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Human-immunodeficiency-virus-type-1-encoded Vpu protein is phosphorylated by casein kinase II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

BST-2 is rapidly down-regulated from the cell surface by the HIV-1 protein Vpu: evidence for a post-ER mechanism of Vpu-action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

A novel gene of HIV-1, vpu, and its 16-kilodalton product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Structural and functional analysis of the membrane-spanning domain of the human immunodeficiency virus type 1 Vpu protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Serine-threonine ubiquitination mediates downregulation of BST-2/tetherin and relief of restricted virion release by HIV-1 Vpu.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

The pericentriolar recycling endosome plays a key role in Vpu-mediated enhancement of HIV-1 particle release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Structural insight into the mechanisms of enveloped virus tethering by tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Nef proteins from simian immunodeficiency viruses are tetherin antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

Human immunodeficiency virus type 1 Vpu protein induces degradation of CD4 in vitro: the cytoplasmic domain of CD4 contributes to Vpu sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

7 January 2021

Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

7 January 2021

Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

7 January 2021

Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.04.009

7 January 2021